SEC Filings TLDR

On August 1, 2025, Andy Fang, a director of DoorDash, Inc., engaged in multiple transactions involving the company's Class A Common Stock. These transactions were executed under a Rule 10b5-1 trading plan adopted on March 6, 2025. Fang converted 30,000 shares of Class B Common Stock to Class A Common Stock and subseque...

On August 4, 2025, Timothy L Olson, a director of Citizens Community Bancorp Inc., purchased 1,471 shares of the company's common stock at a weighted average price of $14.99 per share. The shares were acquired in multiple transactions with prices ranging from $14.91 to $15.01. Following this transaction, Olson owns a t...

On August 4, 2025, R. Joseph Landy, a director of Citizens Financial Services Inc (CZFS), disposed of 20 shares of the company's common class stock. The transaction was reported under Form 4, indicating a change in beneficial ownership. Following this transaction, Landy's total ownership in the company stands at 27,796...

On August 5, 2025, Fady Ibraham Malik, the Executive Vice President of Research & Development at Cytokinetics Inc, reported several stock transactions. Malik exercised a non-qualified stock option to buy 2,000 shares of common stock at $10.60 per share, resulting in a total of 14,261 shares owned following the transact...

Paul Ligon, the Senior Vice President of Sustainable Growth at Casella Waste Systems Inc, sold 1,000 shares of Class A Common Stock on August 4, 2025, at a price of $102.84 per share. This transaction was executed automatically under a Rule 10b5-1 trading plan adopted by Ligon on December 16, 2024. Following the sale, ...

On August 1, 2025, Jared Scott Grachek, the Chief Accounting Officer of Cantaloupe, Inc., was granted 3,739 Restricted Stock Units (RSUs) under the company's long-term stock incentive plans. Each RSU represents a nontransferable right to receive one share of the company's common stock. The RSUs vest on a prorated basis...

On August 1, 2025, Canteloupe, Inc. (CTLP) awarded 7,260 Restricted Stock Units (RSUs) to Gaurav Singal, the company's Chief Technology Officer. Each RSU represents a nontransferable right to receive one share of the company's common stock. The award was granted under the company's long-term stock incentive plans (LTIP...

On August 1, 2025, Anna Novoseletsky, Chief Legal Officer of Cantaloupe, Inc., was granted 6,810 Restricted Stock Units (RSUs) under the company's long-term stock incentive plans. Each RSU represents a nontransferable right to receive one share of the company's common stock. The RSUs vest on a prorated basis over 1,095...

On August 1, 2025, Stewart Scott Matthew, the Chief Financial Officer of Canteloupe, Inc., acquired additional shares of the company's common stock through Restricted Stock Units (RSUs). The first transaction involved 8,095 RSUs, which vest prorated over 1,095 days based on continued service. The second transaction inv...

On August 5, 2025, Canteloupe, Inc. filed a Form 4 with the SEC regarding transactions by Jeffrey Charles Dumbrell, the Chief Revenue Officer. The filing reports the acquisition of 8,095 restricted stock units (RSUs) and 12,500 RSUs on August 1, 2025. The RSUs represent a right to receive one share of common stock each...

On August 1, 2025, Venkatesan Ravi, the Chief Executive Officer and Director of Canteloupe, Inc., acquired 14,593 shares of the company's common stock through Restricted Stock Units (RSUs). These RSUs represent a nontransferable right to receive one share of the company's common stock and were granted under the company...

On August 1, 2025, Saint Frederick G., President of Marketplaces at CoStar Group, Inc., sold 1,436 shares of the company's common stock at a price of $95.19 per share. Following this transaction, Saint Frederick G. owns 318,103 shares of CoStar Group, Inc. The transaction was reported in a Form 4 filing with the SEC. T...

On August 1, 2025, Cann Cynthia Cammett, the Chief Accounting Officer of Costar Group, Inc., sold 719 shares of the company's common stock at a price of $95.19 per share. Following this transaction, she owns 25,052 shares directly. The sale was reported in a Form 4 filing with the SEC, indicating a direct ownership nat...

Sameer K. Gandhi, a director of CrowdStrike Holdings, Inc., reported multiple sales of Class A common stock on August 1, 2025. The transactions were executed at weighted average prices ranging from $439.42 to $453.78 per share, totaling a significant number of shares. The sales were conducted through Potomac Investment...

On August 1, 2025, William Joseph Brennan, President and Chief Executive Officer of Credo Technology Group Holding Ltd (CRDO), filed a Form 4 with the SEC reporting the sale of ordinary shares. The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. Brennan sold a total of 3757 ...

Pantas Sutardja, a director of Credo Technology Group Holding Ltd (CRDO), sold a total of 1,875 ordinary shares on August 1, 2025. The sales were executed at prices ranging from $103.85 to $110.05 per share, with the transactions being part of a Rule 10b5-1 trading plan adopted on June 26, 2024. The sales were conducte...

Cheng Chi Fung, Chief Technology Officer and Director of Credo Technology Group Holding Ltd (CRDO), reported multiple sales of ordinary shares held by the Cheng Huang Family Trust. The transactions, executed on August 1, 2025, were part of a Rule 10b5-1 trading plan adopted on September 6, 2024. The sales were conducte...

Sean Maduck, President of Corcept Endocrinology, reported several transactions involving Corcept Therapeutics Inc. (CORT) common stock. On June 12, 2025, Maduck transferred 10,024 shares to the Sean and Molly Maduck Living Trust and received 10,024 shares from the same trust. On July 3, 2025, he transferred 40,000 shar...

Joseph K. Belanoff, Chief Executive Officer and Director of Corcept Therapeutics Inc., reported multiple sales of the company's common stock on August 1, 2025. The transactions were executed under a Rule 10b5-1 trading plan adopted on November 26, 2024. Belanoff sold a total of 40,000 shares at weighted average prices ...

Joseph Douglas Lyon, the Chief Accounting & Technology Officer of Corcept Therapeutics Inc., reported several transactions involving the company's common stock and stock options. On August 1, 2025, Lyon exercised stock options to acquire 5,823 shares of common stock at an exercise price of $13.56 per share. On the same...

Lisa Kulok, EVP Chief Supply Chain Officer of Columbia Sportswear Co., reported several transactions involving the company's common stock and restricted stock units (RSUs) on August 1, 2025. Kulok acquired 271 and 319 shares of common stock through the vesting of RSUs, increasing her total holdings to 5,507 shares. Add...

Peter J. Bragdon, EVP, CAO, and General Counsel of Columbia Sportswear Co., reported several transactions involving the company's common stock and restricted stock units (RSUs) on August 1, 2025. Bragdon acquired 421 and 464 shares of common stock through the vesting of RSUs, which convert to common stock on a one-for-...

On August 1, 2025, Stephen T. Boswell, a director of ConnectOne Bancorp, Inc., engaged in two transactions involving the company's common stock. In the first transaction, Boswell directly acquired 1,500 shares at a price of $22.25 per share, increasing his direct holdings to 77,674.455 shares. In the second transaction...

On August 1, 2025, Stephen T. Boswell, a director of ConnectOne Bancorp, Inc., engaged in two transactions involving the company's common stock. In the first transaction, Boswell directly acquired 1,500 shares at a price of $22.25 per share, increasing his direct holdings to 77,674.455 shares. In the second transaction...

On August 4, 2025, Daniel Gizinski, President of the S&S Comm. Segment at Comtech Telecommunications Corp, engaged in several stock transactions. He acquired 349 shares of common stock through the vesting of restricted stock units, increasing his total holdings to 23,320 shares. Additionally, 158 shares were withheld t...